CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.
暂无分享，去创建一个
M. Postma | F. Asselbergs | A. de Boer | J. Herrman | T. Bergmeijer | W. Dewilde | V. Deneer | J. T. ten Berg | F. Spanó | J. Kelder | K. Qaderdan | P. Janssen | M. Ishak | A. W. van ’t Hof | J. C. Schipper | Rianne S Ruitenbeek | Khalid Qaderdan